Mylan increases Abbott's ownership stake in pending deal
October 22, 2014 at 08:26 AM EDT
Mylan Inc. said it expects its controversial $5.3 billion deal to acquire Abbott Laboratories' generic European operations and merge, creating a new holding company in the tax-friendlier Netherlands, to close in first quarter 2015...